Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force (2024)
- Authors:
- Autor USP: LAFER, BENY - FM
- Unidade: FM
- DOI: 10.1111/bdi.13414
- Subjects: REPOSICIONAMENTO DE FÁRMACOS; ESTIMULANTES DO SISTEMA NERVOSO CENTRAL; TRANSTORNO BIPOLAR; TRANSTORNOS COGNITIVOS
- Agências de fomento:
- Health Research Council of New Zealand
- European Research Council (ERC) Consolidator Grant
- Dame Kate Campbell Fellowship from the University of Melbourne
- Spanish Ministry of Science and Innovation
- ISCIII-Subdireccion General de Evaluacion
- Fondo Europeo de Desarrollo Regional (FEDER)
- Instituto de Salud Carlos III
- CIBER of Mental Health (CIBERSAM)
- Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement
- CERCA Programme
- Departament de Salut de la Generalitat de Catalunya
- European Research Council (ERC) Funding Source: European Research Council (ERC)
- Language: Inglês
- Imprenta:
- Source:
- Título: Bipolar disorders
- ISSN: 1398-5647
- Volume/Número/Paginação/Ano: v. 26, n. 3, p. 216-239, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MISKOWIAK, Kamilla W et al. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force. Bipolar disorders, v. 26, n. 3, p. 216-239, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/77039. Acesso em: 23 jan. 2026. -
APA
Miskowiak, K. W., Obel, Z. K., Gugliemo, R., Bonnin, C. del M., Bowie, C. R., Balanza-Martinez, V., et al. (2024). Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force. Bipolar disorders, 26( 3), 216-239. doi:10.1111/bdi.13414 -
NLM
Miskowiak KW, Obel ZK, Gugliemo R, Bonnin C del M, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Lafer B. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force [Internet]. Bipolar disorders. 2024 ; 26( 3): 216-239.[citado 2026 jan. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/77039 -
Vancouver
Miskowiak KW, Obel ZK, Gugliemo R, Bonnin C del M, Bowie CR, Balanza-Martinez V, Burdick KE, Carvalho AF, Dols A, Lafer B. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: a systematic review by the ISBD Targeting Cognition Task Force [Internet]. Bipolar disorders. 2024 ; 26( 3): 216-239.[citado 2026 jan. 23 ] Available from: https://observatorio.fm.usp.br/handle/OPI/77039 - Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I
- Rapid cycling bipolar disorder – diagnostic concepts
- Increased illness burden in women with comorbid bipolar and premenstrual dysphoric disorder: data from 1 099 women from STEP-BD study
- Pós-graduação em psiquiatria
- Exercício físico e promoção de saúde mental
- Internet use by older adults with bipolar disorder: international survey results
- Predominant polarity classification and associated clinical variables in bipolar disorder: A machine learning approach
- Cognitive behavioral rehabilitation for bipolar disorder patients: a randomized controlled trial
- Comorbidades médicas em pacientes ambulatoriais com transtorno do humor bipolar tipo I
- Childhood maltreatment and clinical outcomes of bipolar disorder.
Informações sobre o DOI: 10.1111/bdi.13414 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
